Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2020 | Story Dr Nitha Ramnath | Photo Supplied
Devina Harry Kader Asmal Fellowship
The UFS’ Devina Harry was accepted into the Kader Asmal Fellowship Programme.

The UFS’ own Devina Harry is set to travel to Ireland in September 2020 to begin a year-long Fellowship Programme for a Master of Business. As one of 20 students selected from the African continent, Devina was recently accepted into the Kader Asmal Fellowship Programme, which affords her the opportunity to study in Ireland during the 2020/21 academic year.

A research assistant in the Department of Business Management, Devina holds an Honours in Marketing. “I am very grateful to be awarded this scholarship and excited about this new journey,” says Devina, who is scheduled to begin the programme in October 2020. “I hope to come back to South Africa and contribute to my field of study,” she says.

Devina went through a rigorous application process and had to meet the criteria for selection, one of which is having a minimum average grade point of 75% for her honours.

Prof Brownhilder Nene, Head of Department: Business Management, gave Devina some words of encouragement: “You will never know how far you can go unless you try. Thank you, Devina, for stepping out of your comfort zone and getting this scholarship.” 

The Kader Asmal Fellowship Programme is a South African strand of a broader Ireland-Africa Fellows Programme managed by the Irish Department of Foreign Affairs and Trade. It was set up in 2012 in honour of the late Professor Kader Asmal, and is a fully-funded scholarship opportunity for those who want to develop skills and knowledge to contribute to the achievement of the Sustainable Development Goals in South Africa.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept